World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-TRC-14005143
Date of registration: 2014-08-14
Prospective Registration: Yes
Primary sponsor: The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Public title: A traditional chinese medicine clinical intervention study of depressed Parkinson's disease - based on the Wenyang Jieyu method
Scientific title: A traditional chinese medicine clinical intervention study of depressed Parkinson's disease - based on the Wenyang Yieyu method
Date of first enrolment: 2014-08-25
Target sample size: Chinese Medicines:60;Western Medicine group:60;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=4432
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  II (Phase II study)
Countries of recruitment
China
Contacts
Name: Xiaoli Li   
Address:  51 XiaoGuanStreet, AnDingMen, ChaoYang District, Beijing
Telephone: +86 13521039619
Email: tigerlxl2002@163.com
Affiliation: 
Name: Xiaomei Liu   
Address:  51 XiaoGuanStreet, AnDingMen, ChaoYang District, Beijing
Telephone: +86 18811506035
Email: lxllcsyzc2014@163.com
Affiliation:  The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Key inclusion & exclusion criteria
Inclusion criteria: 1. Age: 55-75 years old;
2. Patients were diagnosed of PDD by western medicine;
3. Patients meet Modified Hoehn-Yahr Parkinson's disease within four grading standards;
4. Patients get 18-35 points in 24 HAMD score standards;
5. Patients belong to Chinese medicine kidney deficiency liver depressive type syndromes;
6. Subjects informed, voluntary informed consent, a certain reading skills;
7. Those who meet the above six, selected.

Exclusion criteria: 1. Had received primary surgical treatment of Parkinson's disease;
2. With severe heart, liver, kidney disease, blood disorders and cancer patients;
3. Have a history of mental illness;
4. Have suicide attempts were;
5. Allergies;
6. The observation of other syndromes of TCM syndromes beyond.


Age minimum: 55
Age maximum: 75
Gender: Both
Health Condition(s) or Problem(s) studied
Depressed Parkinson's disease
Intervention(s)
Chinese Medicines:Formula granule;Western Medicine group:Venlafaxine hydrochloride sustained-release capsules ;
Primary Outcome(s)
Hamilton's Depression Scale;TCM Syndrome rating scale;
Secondary Outcome(s)
Parkinson's disease composite score table (UPDRS II, III section);
Secondary ID(s)
Source(s) of Monetary Support
Beijing Municipal Science and Technology Commission
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history